178 related articles for article (PubMed ID: 9257944)
1. Characterization of [125I]S(-)5-OH-PIPAT binding to dopamine D2-like receptors expressed in cell lines.
Vessotskie JM; Kung MP; Chumpradit S; Kung HF
Neuropharmacology; 1997 Jul; 36(7):999-1007. PubMed ID: 9257944
[TBL] [Abstract][Full Text] [Related]
2. Quantitative autoradiographic studies of dopamine D3 receptors in rat cerebellum using [125I]S(-)5-OH-PIPAT.
Vessotskie JM; Kung MP; Chumpradit S; Kung HF
Brain Res; 1997 Dec; 778(1):89-98. PubMed ID: 9462880
[TBL] [Abstract][Full Text] [Related]
3. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle.
Burris KD; Filtz TM; Chumpradit S; Kung MP; Foulon C; Hensler JG; Kung HF; Molinoff PB
J Pharmacol Exp Ther; 1994 Feb; 268(2):935-42. PubMed ID: 8114008
[TBL] [Abstract][Full Text] [Related]
4. Lack of discrimination by agonists for D2 and D3 dopamine receptors.
Burris KD; Pacheco MA; Filtz TM; Kung MP; Kung HF; Molinoff PB
Neuropsychopharmacology; 1995 Jul; 12(4):335-45. PubMed ID: 7576010
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
Kung MP; Stevenson DA; Zhuang ZP; Vessotskie JM; Chumpradit S; Sun XM; Kung HF
Life Sci; 1997; 60(2):91-100. PubMed ID: 9000114
[TBL] [Abstract][Full Text] [Related]
6. Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
Chumpradit S; Kung MP; Vessotskie J; Foulon C; Mu M; Kung HF
J Med Chem; 1994 Nov; 37(24):4245-50. PubMed ID: 7990123
[TBL] [Abstract][Full Text] [Related]
7. Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain.
Kung MP; Chumpradit S; Frederick D; Garner S; Burris KD; Molinoff PB; Kung HF
Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):611-7. PubMed ID: 7708118
[TBL] [Abstract][Full Text] [Related]
8. In vitro binding of a novel dopamine D3 receptor ligand: [125I]trans-7-OH-PIPAT-A.
Kung MP; Kung HF; Chumpradit S; Foulon C
Eur J Pharmacol; 1993 Apr; 235(1):165-6. PubMed ID: 8519278
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of (R,S)-trans-8-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'-propenyl)amino]tetral in (trans-8-OH-PIPAT): a new 5-HT1A receptor ligand.
Zhuang ZP; Kung MP; Kung HF
J Med Chem; 1993 Oct; 36(21):3161-5. PubMed ID: 8230102
[TBL] [Abstract][Full Text] [Related]
10. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
Gurevich EV; Bordelon Y; Shapiro RM; Arnold SE; Gur RE; Joyce JN
Arch Gen Psychiatry; 1997 Mar; 54(3):225-32. PubMed ID: 9075463
[TBL] [Abstract][Full Text] [Related]
11. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy.
Millan MJ; Peglion JL; Vian J; Rivet JM; Brocco M; Gobert A; Newman-Tancredi A; Dacquet C; Bervoets K; Girardon S
J Pharmacol Exp Ther; 1995 Nov; 275(2):885-98. PubMed ID: 7473180
[TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study.
Amenta F; Bronzetti E; Felici L; Ricci A; Tayebati SK
J Auton Pharmacol; 1999 Jun; 19(3):151-9. PubMed ID: 10511471
[TBL] [Abstract][Full Text] [Related]
14. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
Patel S; Patel S; Marwood R; Emms F; Marston D; Leeson PD; Curtis NR; Kulagowski JJ; Freedman SB
Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990
[TBL] [Abstract][Full Text] [Related]
15. [3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors.
Gonzalez AM; Sibley DR
Eur J Pharmacol; 1995 Jan; 272(1):R1-3. PubMed ID: 7713138
[TBL] [Abstract][Full Text] [Related]
16. Labeling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with [3H]7-OH-DPAT: a combined radioligand binding assay and immunochemical study.
Ricci A; Bronzetti E; Felici L; Greco S; Amenta F
J Neuroimmunol; 1998 Dec; 92(1-2):191-5. PubMed ID: 9916894
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
Booze RM; Wallace DR
Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
[TBL] [Abstract][Full Text] [Related]
18. Expression and pharmacological characterization of the human D3 dopamine receptor.
Freedman SB; Patel S; Marwood R; Emms F; Seabrook GR; Knowles MR; McAllister G
J Pharmacol Exp Ther; 1994 Jan; 268(1):417-26. PubMed ID: 8301582
[TBL] [Abstract][Full Text] [Related]
19. [125I](S)-trans-7-OH-PIPAT: a potential spect imaging agent for sigma binding sites.
Garner SE; Kung MP; Foulon C; Chumpradit S; Kung HF
Life Sci; 1994; 54(9):593-603. PubMed ID: 8114613
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells.
Coldwell MC; Boyfield I; Brown AM; Stemp G; Middlemiss DN
Br J Pharmacol; 1999 Jul; 127(5):1135-44. PubMed ID: 10455259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
